Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Assumes Skillsoft at Perform

Oppenheimer Assumes Skillsoft at Perform

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.

Analyst Ratings

Forecasting The Future: 7 Analyst Projections For Regal Rexnord

By Benzinga Insights

June 4, 12:00 PM

Throughout the last three months, 7 analysts have evaluated Regal Rexnord (NYSE:RRX), offering a diverse set of opinions…

RRX

X Has Bad Timing With Tech Issues Thursday After Rival Threads Reports 100M Users: Inside The Struggles Of Elon Musk’s Company In 2023

By Chris Katje

October 26, 1:22 PM

Tweets weren't visible Thursday morning while Thread reports 100 million users.

Worried About Data Loss in Emails? Zscaler’s Latest Innovations Have You Covered – Read How

By Nabaparna Bhattacharya

May 14, 8:37 AM

Zscaler enhances its AI Data Protection Platform with integrated DSP and GenAI App Security, offering real-time Email DLP and consolidating data protection efforts while achieving high performance and recognition in Q2.

BUG

Vaxcyte Announces Pricing Of $600M Public Offering Of 15M Shares Of Common Stock At A Price Of $32/Share

By Benzinga Newsdesk

October 26, 12:36 AM

Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the pricing of an underwritten

PCVX

Oppenheimer Assumes Skillsoft at Perform

Related Posts

Forecasting The Future: 7 Analyst Projections For Regal Rexnord

X Has Bad Timing With Tech Issues Thursday After Rival Threads Reports 100M Users: Inside The Struggles Of Elon Musk’s Company In 2023

Worried About Data Loss in Emails? Zscaler’s Latest Innovations Have You Covered – Read How

Vaxcyte Announces Pricing Of $600M Public Offering Of 15M Shares Of Common Stock At A Price Of $32/Share